Cas:76271-74-4 2-((tert-Butyldiphenylsilyl)oxy)acetic acid manufacturer & supplier

Chemical Name:2-((tert-Butyldiphenylsilyl)oxy)acetic acid

CAS.NO:76271-74-4

Synonyms:t-butyldiphenylsilyloxyacetic acid;2-(tert-butyl diphenylsilyloxy)acetic acid;{[tert-Butyl(diphenyl)silyl]oxy}acetic Acid;Acetic acid, 2-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-;Acetic acid,[[(1,1-dimethylethyl)diphenylsilyl]oxy];2-((t-butyldiphenylsilyl)oxy)acetic acid;{[(2-Methyl-2-propanyl)(diphenyl)silyl]oxy}acetic acid

Molecular Formula:C₁₈H₂₂O₃Si

Molecular Weight:314.451

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:395.1±34.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.554

PSA:46.53000

Exact Mass:314.133820

LogP:5.99

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like t-butyldiphenylsilyloxyacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,{[(2-Methyl-2-propanyl)(diphenyl)silyl]oxy}acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,{[(2-Methyl-2-propanyl)(diphenyl)silyl]oxy}acetic acid Use and application,{[tert-Butyl(diphenyl)silyl]oxy}acetic Acid technical grade,usp/ep/jp grade.

Related News: Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. 4-(3-ethoxy-phenyl)-thiosemicarbazide manufacturers Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor. (4-(4-chlorophthalazin-1-yl)piperazin-1-yl)(phenyl)methanone suppliers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. (E)-6-(tert-Butyl-dimethyl-silanyloxy)-5,5-dimethyl-8-trimethylsilanyl-oct-2-en-7-ynoic acid ethyl ester vendor & factory.